Integrating Smoking Cessation With Low-dose CT-screening for Lung Cancer
ConditionSmoking Cessation
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-74
SponsorOulu University Hospital
About this trial
The study investigates effectiveness of different smoking cessation methods and low-dose CT based lung cancer screening
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Able to provide written informed consent
Age between 50-74
Smoked ≥ 15 cigarettes/day for ≥ 25 years or smoked ≥ 10 cigarettes/day for ≥ 30 years and are active smokers (smoking during the last two weeks)
Access to a smartphone (iPhone or Android)
Disqualifiers
Current or past melanoma, lung, renal or breast cancer
A chest CT examination less than one year before inclusion
Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial
No access to a smartphone (iPhone or Android)
Trial design
Design model
Parallel
Treatments tested in this trial
Smartphone application
Other interventionSuunta smartphone application for smoking cessation
low-dose computed tomography
Other interventionLow-dose computed tomography based screening for lung cancer
Written materials for smoking cessation
Other interventionWritten materials for smoking cessation
Treatment groups
1,200 Participants
are divided into 3 treatment groupsGroup A: Arm 1Experimental treatment 2 interventions
Group B: Arm 2Active comparator 2 interventions
Group C: Arm 3Active comparator 1 intervention
Trial outcomes
Primary outcomes
1
Rate of smoking cessation
The percentage of participants who have quitted smoking between the study arms 1 vs. 2
Time frame
three monthsSecondary outcomes
1
Rate of smoking cessation
The percentage of participants who have quitted smoking between all the study arms
Time frame
Three months2
Rate of smoking cessation
The percentage of participants who have quitted smoking between all the study arms
Time frame
12 and 24 months3
Rate of long-term smoking cessation
The percentage of participants who have had abstinence of smoking for at least six months
Time frame
12 and 24 moths4
LDCT findings
The percentage of LDCT negative, indetermined, and positive findings by screening round
Time frame
baseline and 24 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Oulu University Hospital
Lead sponsor
Finnish Cancer Society
Collaborator
Source ClinicalTrials.gov